Overview

Clinical Pharmacology Study of MP-424

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
To conduct the following evaluations in Korean healthy male adult volunteers receiving a single and multiple doses of MP-424 tablets: - Pharmacokinetics of MP-424 after a single and multiple doses. - Safety and tolerability of single and multiple doses of MP-424.
Phase:
Phase 1
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation